0000905718-16-001790.txt : 20161129
0000905718-16-001790.hdr.sgml : 20161129
20161129164629
ACCESSION NUMBER: 0000905718-16-001790
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20161129
DATE AS OF CHANGE: 20161129
EFFECTIVENESS DATE: 20161129
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Celldex Therapeutics, Inc.
CENTRAL INDEX KEY: 0000744218
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 133191702
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-275294
FILM NUMBER: 162023216
BUSINESS ADDRESS:
STREET 1: 53 FRONTAGE ROAD
STREET 2: SUITE 220
CITY: HAMPTON
STATE: NJ
ZIP: 08827
BUSINESS PHONE: 908-200-7500
MAIL ADDRESS:
STREET 1: 53 FRONTAGE ROAD
STREET 2: SUITE 220
CITY: HAMPTON
STATE: NJ
ZIP: 08827
FORMER COMPANY:
FORMER CONFORMED NAME: AVANT IMMUNOTHERAPEUTICS INC
DATE OF NAME CHANGE: 19980828
FORMER COMPANY:
FORMER CONFORMED NAME: T CELL SCIENCES INC
DATE OF NAME CHANGE: 19920703
D
1
primary_doc.xml
X0707
D
LIVE
0000744218
Celldex Therapeutics, Inc.
53 FRONTAGE ROAD, SUITE 220
HAMPTON
NJ
NEW JERSEY
08827
908-200-7500
DELAWARE
None
AVANT IMMUNOTHERAPEUTICS INC
T CELL SCIENCES INC
Corporation
true
Herbert
J.
Conrad
c/o Celldex Therapeutics Inc.
53 Frontage Road, Suite 220
Hampton
NJ
NEW JERSEY
08827
Director
Larry
Ellberger
c/o Celldex Therapeutics Inc.
53 Frontage Road, Suite 220
Hampton
NJ
NEW JERSEY
08827
Director
George
O.
Elston
c/o Celldex Therapeutics Inc.
53 Frontage Road, Suite 220
Hampton
NJ
NEW JERSEY
08827
Director
Karen
Shoos
c/o Celldex Therapeutics Inc.
53 Frontage Road, Suite 220
Hampton
NJ
NEW JERSEY
08827
Director
Anthony
S.
Marucci
c/o Celldex Therapeutics Inc.
53 Frontage Road, Suite 220
Hampton
NJ
NEW JERSEY
08827
Executive Officer
Director
Harry
H.
Penner, Jr.
c/o Celldex Therapeutics Inc.
53 Frontage Road, Suite 220
Hampton
NJ
NEW JERSEY
08827
Director
Richard
van den Broek
c/o Celldex Therapeutics Inc.
53 Frontage Road, Suite 220
Hampton
NJ
NEW JERSEY
08827
Director
Avery
W.
Catlin
c/o Celldex Therapeutics Inc.
53 Frontage Road, Suite 220
Hampton
NJ
NEW JERSEY
08827
Executive Officer
Biotechnology
Decline to Disclose
- 06b
false
2016-11-29
false
true
true
At closing our wholly owned subsidiary merged with and into Kolltan Pharmaceuticals, Inc. and Kolltan became our whollyowned subsidiary. Kolltan's investors received 18,257,996 shares of our stock.
0
62500000
62500000
0
Excludes milestone payments of up to $172.5 million which may be made in cash or shares or a combination thereof.
false
29
0
0
0
true
false
Celldex Therapeutics, Inc.
/s/ Avery W. Catlin
Avery W. Catlin
Senior Vice President, CFO
2016-11-29